Up a level |
(2014) Rosiglitazone, a PPAR gamma agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells. Cell Biochemistry and Function. pp. 683-691. ISSN 0263-6484
(2014) Rosiglitazone, a PPARγ agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells. Cell Biochemistry and Function. pp. 683-691. ISSN 02636484 (ISSN)